Jason is a Partner & Senior Managing Director in Deloitte’s Corporate Finance practice and leads the prJason is the Chief Business Officer for Entos Pharmaceuticals.  Prior to joining Entos in 2022, Jason was a Partner & Senior Managing Director in Deloitte’s Corporate Finance practice and the National M&A leader for the firm’s life sciences and healthcare practice in Canada focused on mergers & acquisitions, licensing and partnering, capital raises and business valuations, leading transactions with a cumulative value of over $1.5 billion in 2020 and 2021.

Jason started his accounting and finance career at KPMG and Deloitte before leaving to become an Executive-in-Residence a large technology incubator tied to the University of Alberta. In this role, he was responsible for creating and scaling a new provincial life science accelerator focused on achieving economic development metrics, building a supportive ecosystem and growing industry partnerships. Additional responsibilities included being a contract executive, advising entrepreneurs, company formation and knowledge translation for early stage and start-up companies, market and opportunity assessments, and go-to-market strategies.  Jason rejoined Deloitte in 2017.

Prior to working in the financial industry, Jason worked as a science reporter for CBC radio, an Ombudsman for the University of Alberta, and in a variety of research labs.  He is a Fellow of the Institute of Chartered Professional Accountants of Alberta, Chartered Business Valuator and holds the ICD.D designation and was part of the class of Top 40 under 40 Edmonton in 2016.  Jason currently serves on the board of directors of the Telus World of Science Edmonton, BioAlberta and the Canadian Entrepreneurs in Life Sciences organization (“CELS”).